Attributes | Values |
---|
rdf:type
| |
Description
| - Both newly developed oximes (K206, K269) are significantly more efficacious in reactivating tabun-inhibited AChE in rats and to eliminate lethal toxic effects of tabun in mice than the oxime HI-6 but their reactivating and therapeutic potency does not prevail over the effectiveness of currently available obidoxime and trimedoxime.
- Both newly developed oximes (K206, K269) are significantly more efficacious in reactivating tabun-inhibited AChE in rats and to eliminate lethal toxic effects of tabun in mice than the oxime HI-6 but their reactivating and therapeutic potency does not prevail over the effectiveness of currently available obidoxime and trimedoxime. (en)
- Oba nově vyvinuté oximy (K206, K269) jsou signifikantně účinnější při reaktivaci tabunem inhibované AChE u potkanů a při eliminaci letálních toxických účinků tabunu u myší než oxim HI-6, ale jejich reaktivační a terapeutický účinek nepřevažuje nad účinkem v současnosti používaného obidoximu a trimedoximu. (cs)
|
Title
| - A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice
- A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice (en)
- Srovnání terapeutické a reaktivační účinnosti nově vyvinutých bispyridiniových sloučenin (K206, K269) se v současnosti dostupnými oximy proti tabunu na potkanech a myších (cs)
|
skos:prefLabel
| - A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice
- A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice (en)
- Srovnání terapeutické a reaktivační účinnosti nově vyvinutých bispyridiniových sloučenin (K206, K269) se v současnosti dostupnými oximy proti tabunu na potkanech a myších (cs)
|
skos:notation
| - RIV/60162694:G44__/08:00001943!RIV09-MO0-G44_____
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/08:00001943
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - tabun; acetylcholinesterase; reactivation; K206; K269; obidoxime; trimedoxime; HI-6; inhibition; acetylthiocholine (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Enzyme Inhibition and Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Bajgar, Jiří
- Kassa, Jiří
- Kuča, Kamil
- Musílek, Kamil
- Karasová, Jana
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |